Natalizumab in Multiple Sclerosis: Long-Term Management

Natalizumab is a monoclonal antibody highly effective in the treatment of relapsing remitting multiple sclerosis (RRMS) patients. Despite its effectiveness, there are growing concerns regarding the risk of progressive multifocal leukoencephalopathy (PML), a brain infection caused by John Cunningham...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Int J Mol Sci
मुख्य लेखकों: Clerico, Marinella, Artusi, Carlo Alberto, Di Liberto, Alessandra, Rolla, Simona, Bardina, Valentina, Barbero, Pierangelo, De Mercanti, Stefania Federica, Durelli, Luca
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI 2017
विषय:
Review
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5454853/
https://ncbi.nlm.nih.gov/pubmed/28468254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18050940
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन